FDA’s choice to become the new director of the Office of Generic Drugs appears to be more familiar with the brand side of the business, experience that may concern stakeholders as OGD prepares for a major expansion.
FDA Office Of Generic Drugs Director Has Brand Industry Background
Gregory Geba mostly has brand experience, but will be expected to lead OGD’s reorganization as it implements a new user fee program.